Associate Professor, Medicine, Perelman School of Medicine
Oncology
Dr. Donald E. Tsai, MD
|
|
Give Review
Doctor Donald E. Tsai, MD is an expert in the field of Oncology. He researched medicine at Duke University School of Medicine. Duke University School of Medicine is one of the top medical schools in the US. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He received awards:"CMS Meaningful Use Stage 1 Certification". Donald Tsai has written publications. He has 77 publications published with PubMed. The lastest publication is: 'Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder.' He is registered with Medicare and accepts Medicare payments.
Publications
- Shaping the Molecular Landscape of Posttransplantation Lymphoproliferative Disorders.
- Subcutaneous Veltuzumab, a Humanized Anti-CD20 Antibody, in the Treatment of Refractory Pemphigus Vulgaris.
- A pilot trial of quantitative Epstein-Barr virus polymerase chain reaction in patients undergoing treatment for their malignancy: potential use of Epstein-Barr virus p...
- Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: A report of 5 cases from the Southern Network on Adverse Reactions (SONAR) proj...
- Receipt of maintenance therapy is most predictive of survival in older Acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens.
- Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.
- Post-transplant lymphoproliferative disorder after Lung transplantation: A review of 35 cases.
- Successful treatment of angioimmunoblastic T-cell Lymphoma with the retinoid X receptor agonist, bexarotene.
- Treatment advances in posttransplant lymphoproliferative Disease.
- Posttransplant lymphoproliferative disorder following kidney transplant.
- A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory Acute myelogenous leukemia.
- Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report.
- Successful treatment of relapsed Lymphomatoid granulomatosis with bexarotene.
- A phase I study of bexarotene, a retinoic X receptor agonist, in non-M3 Acute myeloid leukemia.
- Hypertriglyceridemia presenting as "pink blood" and elevated hemoglobin level.
- Differentiation syndrome in non-M3 Acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
- Post-transplant outcomes of induction therapy for Myeloma: thalidomide and dexamethasone versus doxorubicin, vincristine, and dexamethasone prior to high-dose melphala...
- Posttransplant lymphoproliferative disorder.
- Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's Lymphoma.
- Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of Acute lung allograft rejection.
- The management of posttransplant lymphoproliferative disorder.
- Evidence of myeloid differentiation in non-M3 Acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene.
- A peptide-based inhibitor for prevention of B Cell hyperproliferation induced by Epstein-Barr virus.
- Post-transplant lymphoproliferative disorder.
- Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative Disease using B-cell-directed therapy.
- Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's Lymphoma can simulate Lymphoma involvement in marrow.
- Radioimmunotherapy of non-Hodgkin's Lymphoma with 90Y-DOTA humanized anti-CD22 IgG (90Y-Epratuzumab): do tumor targeting and dosimetry predict therapeutic response?
- Use of ibritumomab tiuxetan anti-CD20 radioimmunotherapy in a non-Hodgkin's Lymphoma patient previously treated with a yttrium-90-labeled anti-CD22 monoclonal antibody.
- Rituximab for PTLD of the CNS: is it a ''no-Brainer''?
- Detection of Epstein-Barr virus in T-cell prolymphocytic Leukemia cells in vitro.
- Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases.
- Primary Lymphomas of the cervix and uterus: the University of Pennsylvania''s experience and a review of the literature.
- Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.
- Successful treatment of T-cell post-transplant lymphoproliferative disorder with the retinoid Analog bexarotene.
- Gemcitabine-induced pericardial effusion and tamponade after unblocked cardiac irradiation.
- Regression of advanced non-splenic marginal zone Lymphoma after treatment of hepatitis C virus infection.
- Regression of pulmonary MALT Lymphoma after treatment with rituximab.
- Serum protein electrophoresis abnormalities in adult solid organ transplant patients with post-transplant lymphoproliferative disorder.
- Use of iodine 131I-toSitumomab radioimmunotherapy in a patient with Waldenstrom''s macroglobulinemia.
- Use of serum protein electrophoresis to monitor patients with post-transplant lymphoproliferative disorder.
- Improvement in Sjögren's syndrome following therapy with rituximab for marginal zone Lymphoma.
- Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients.
- Combined radiation and chemotherapy in posttransplant lymphoproliferative disorder.
- Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(?).
- Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin''s Lymphoma after high-dose therapy and autologous peripheral stem cel...
- Post-transplant lymphoproliferative disorder: a review.
- Allogeneic Cell therapy for patients who relapse after autologous stem Cell transplantation.
- Progressive intermediate-grade non-Hodgkin's Lymphoma after high-dose therapy and autologous peripheral stem-cell transplantation: changing the natural history with mo...
- Stem cell transplantation for metastatic breast cancer: Analysis of tumor contamination.
- Removal of gadolinium by peritoneal dialysis.
- Treatment of PTLD with rituximab or chemotherapy.
- Clinical studies of Cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
- Expression of SHP-1 phosphatase indicates post-germinal center cell derivation of B-cell posttransplant lymphoproliferative Disorders.
- Leukemic gingival infiltrate as an indicator of chemotherapeutic failure following monoclonal antibody therapy: a case report.
- Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative Disorders.
- EBV PCR in the diagnosis and monitoring of posttransplant lymphoproliferative disorder: results of a two-arm prospective trial.
- Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: Analysis of prognostic variables and long-term follow-up of 42 adult...
- Intensive Graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation.
- Homocysteine and prothrombin fragment 1+2 levels in patients with veno-occlusive Disease after stem cell transplantation.
- Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive Disease.
- A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
- A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation.
- Orbital presentation of posttransplantation lymphoproliferative disorder: a small case series.
- Antibody-mediated rejection in heart transplant recipients: potential efficacy of B-Cell depletion and antibody removal.
- Nonmyeloablative allogeneic stem cell transplantation for refractory Hodgkin''s Lymphoma complicated by interleukin-2 responsive progressive multifocal leukoencephalop...
- Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular Lymphoma.
- Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory Acute GVHD.
- Prognostic value of FDG-PET scan imaging in Lymphoma patients undergoing autologous stem cell transplantation.
- Second auto-SCT is safe and effective salvage therapy for relapsed multiple Myeloma.
- Morphine-augmented cholescintigraphy: its efficacy in detecting Acute cholecystitis.
- Variability in the biological response to anti-CD20 B cell depletion in Systemic lupus erythaematosus.
- Indium-111-leukocyte imaging in Acute cholecystitis.
- In vitro selection of an RNA epitope immunologically cross-reactive with a peptide.
- U1-snRNP-A protein selects a ten nucleotide consensus sequence from a degenerate RNA pool presented in various structural contexts.
- In vitro selection of RNA epitopes using autoImmune patient serum.
- Stereotactic radiosurgery for Brain metastases: comparison of lung carcinoma vs. non-lung tumors.
Schools
Duke University School Of Medicine
Hospital Of The University Penn
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Pennsylvania Health System -
Duke University School of Medicine
Hospital
-
Hospital of the University of Pennsylvania
Helpful Reviews
Similar Doctors
|
|
Dr. Anthony J. Olszanski, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ranee Mehra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dale Bryansmith, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Holly Dushkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Angela R. Bradbury, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Efrat Dotan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Roland E. Knoblauch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Meghan S. Karuturi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Margaret T. Kasner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Faith M. Young, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lynn M. Schuchter, MD
This Doctor is OpenDoctor Recommended.
|